New pill tested to tame painful gout flares
NCT ID NCT07498647
Summary
This study is testing a new oral medication called BR2251 to see if it can safely lower high uric acid levels in people with gout. Researchers will compare three different doses of BR2251 against a standard gout medication over 12 weeks in 160 participants. The main goal is to find the most effective dose for controlling uric acid and reducing gout attacks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT AND HYPERURICEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.